Related references
Note: Only part of the references are listed.Comparison of Mobility Indices for Predicting Early Death in Older Patients With Cancer: The Physical Frailty in Elderly Cancer Cohort Study
Frederic Pamoukdjian et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE
Eurydice Angeli et al.
AGING-US (2020)
The prognostic value of the C-reactive protein to albumin ratio in cancer An updated meta-analysis
Xinhua Cui et al.
MEDICINE (2020)
Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype
Frederic Pamoukdjian et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Understanding cachexia in the context of metastatic progression
Anup K. Biswas et al.
NATURE REVIEWS CANCER (2020)
Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies
Mohammed Dagher et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Cancer cachexia: Diagnosis, assessment, and treatment
Mohammadamin Sadeghi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer
Zuqiang Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
Seigo Minami et al.
LUNG CANCER-TARGETS AND THERAPY (2017)
Frailty and sarcopenia: The potential role of an aged immune system
Daisy Wilson et al.
AGEING RESEARCH REVIEWS (2017)
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
Xiao-li Wei et al.
BMC CANCER (2015)
Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer
Xuechao Liu et al.
TRANSLATIONAL ONCOLOGY (2015)
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data
Antonio Rossi et al.
LANCET ONCOLOGY (2014)
Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study
Pierre Soubeyran et al.
PLOS ONE (2014)
Cancer cachexia-pathophysiology and management
Hajime Suzuki et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
Danijela Gnjidic et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Clinical practice guidelines from the French health high authority: Nutritional support strategy in protein-energy malnutrition in the elderly
Agathe Raynaud-Simon et al.
CLINICAL NUTRITION (2011)
Kml: A package to cluster longitudinal data
Christophe Genolini et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2011)
How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials
Belinda E. Kiely et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Share Paper
